A private company advising the agency that oversees Medicare has recommended against reimbursing for the biomarker tests, ...

Coverage and future reimbursement (effective August 10, 2026) secured for NASHnext®, Labcorp’s non-invasive blood-based diagnostic test powered ...

A new Mayo Clinic study shows that integrating telomere length evaluation and genetic testing into pulmonary care can ...

Incogni has wide-reaching coverage, but it lacks third-party efficacy testing data.

One analyst called the insurer’s decision a “watershed moment” for liquid biopsy-based cancer screening and for the category ...

AI-speed risk requires identity-defined reachability within Zero Trust, reducing exposure and enabling continuous policy ...

During Intersolar Europe 2026, Huawei Digital Power, together with global partners, held the inaugural 2026 PV & ESS Safety ...

U.S. patients flagged with moderate or severe AS, based on an initial echocardiogram, ended up getting all their confirmatory diagnostic assessments within 30 days in 61.4% of cases in 2024, up from ...

Coverage is the real problem, not detection. The teams that will thrive over the next five years are the ones rebuilding ...

Background Hospital-centred operational governance has been a persistent feature of China’s health system. While this model ...

For children with suspected rare diseases, access to timely genomic testing remains uneven and, too often, out of reach. Too ...

Preparing for this year’s elephantine tournament has been a big test for our newly expanded football team and our for the developers behind things like our Bracketology game. Here’s how they got match ...